Aksenov MY - Search Results

1

Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.

Aksenov MY, Aksenova MV, Markesbery WR, Butterfield DA. Aksenov MY, et al. J Mol Neurosci. 1998 Jun;10(3):181-92. doi: 10.1007/BF02761773. J Mol Neurosci. 1998. PMID: 9770641

2

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.

Aksenov MY, Aksenova MV, Butterfield DA, Hensley K, Vigo-Pelfrey C, Carney JM. Aksenov MY, et al. J Neurochem. 1996 May;66(5):2050-6. doi: 10.1046/j.1471-4159.1996.66052050.x. J Neurochem. 1996. PMID: 8780035

3

alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity.

Aksenova MV, Aksenov MY, Butterfield DA, Carney JM. Aksenova MV, et al. Among authors: aksenov my. Neurosci Lett. 1996 Jun 14;211(1):45-8. doi: 10.1016/0304-3940(96)12717-8. Neurosci Lett. 1996. PMID: 8809844

4

Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.

Aksenov MY, Aksenova MV, Carney JM, Butterfield DA. Aksenov MY, et al. Neurosci Lett. 1996 Oct 18;217(2-3):117-20. Neurosci Lett. 1996. PMID: 8916086

5

The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.

Aksenov MY, Aksenova MV, Payne RM, Smith CD, Markesbery WR, Carney JM. Aksenov MY, et al. Exp Neurol. 1997 Aug;146(2):458-65. doi: 10.1006/exnr.1997.6550. Exp Neurol. 1997. PMID: 9270056

6

Oxidative modification of glutamine synthetase by amyloid beta peptide.

Aksenov MY, Aksenova MV, Carney JM, Butterfield DA. Aksenov MY, et al. Free Radic Res. 1997 Sep;27(3):267-81. doi: 10.3109/10715769709065765. Free Radic Res. 1997. PMID: 9350431

7

Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.

Aksenova MV, Aksenov MY, Payne RM, Trojanowski JQ, Schmidt ML, Carney JM, Butterfield DA, Markesbery WR. Aksenova MV, et al. Among authors: aksenov my. Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):158-65. doi: 10.1159/000017098. Dement Geriatr Cogn Disord. 1999. PMID: 10026391

8

The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, Estus S, Markesbery WR. Aksenov MY, et al. J Mol Neurosci. 1998 Oct;11(2):151-64. doi: 10.1385/JMN:11:2:151. J Mol Neurosci. 1998. PMID: 10096042

9

Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture.

DeAtley SM, Aksenov MY, Aksenova MV, Jordan B, Carney JM, Butterfield DA. DeAtley SM, et al. Among authors: aksenov my. Toxicology. 1999 May 3;134(1):51-62. doi: 10.1016/s0300-483x(99)00039-6. Toxicology. 1999. PMID: 10413188

10

Aging in a dish: age-dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long-term hippocampal cell culture.

Aksenova MV, Aksenov MY, Markesbery WR, Butterfield DA. Aksenova MV, et al. Among authors: aksenov my. J Neurosci Res. 1999 Oct 15;58(2):308-17. J Neurosci Res. 1999. PMID: 10502287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters